A magic bullet for mucosal protection...and aspirin is the trigger!

Trends in Pharmacological Sciences

Volumn 24, Issue 7, 2003, Pages 323-326

  Wallace, John L ^a   Fiorucci, Stefano ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONATE 5 LIPOXYGENASE; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; LIPOXIN A; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; HYDROXYICOSATETRAENOIC ACID; ISOENZYME; LIPOXIN; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN;

ADAPTATION; BACTERIAL COLONIZATION; CLINICAL TRIAL; COLITIS; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; GASTRITIS; HUMAN; LEUKOCYTE ADHERENCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOMACH HEMORRHAGE; STOMACH MUCOSA; STOMACH PROTECTION; STOMACH ULCER; VASCULAR ENDOTHELIUM; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG SYNERGISM; GASTRIC MUCOSA; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; ISOENZYMES; LIPOXINS; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0042233664     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(03)00166-4     Document Type: Short Survey

References (20)

1. Wallace J.L., Granger D.N. The cellular and molecular basis of gastric mucosal defense. FASEB J. 10:1996;731-740.
2. Flower R.J. Case history: the development of COX2 inhibitors. Nat. Rev. Drug Discov. 2:2003;179-191.
3. Wallace J.L., et al. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology. 119:2000;706-714.
4. 4 increases gastric resistance to aspirin-induced damage. Gastroenterology. 123:2002;1598-1606.
5. Fiorucci S., et al. Celecoxib exacerbates gastrointestinal damage induced by aspirin but not by NO-aspirin (NCX-4016): a randomized, parallel group, blind-observer endoscopic study. Gastroenterology. 124:2003;A93.
6. Claria J., Serhan C.N. Aspirin triggers previously unrecognized bioactive eicosanoids in human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. U. S. A. 92:1995;9475-9479.
7. Abramson S., et al. Modes of action of aspirin-like drugs. Proc. Natl. Acad. Sci. U. S. A. 82:1985;7227-7231.
8. Serhan C.N., Oliw E. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J. Clin. Invest. 107:2001;1481-1489.
9. 4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J. Clin. Invest. 92:1993;75-82.
10. Wallace J.L. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology. 112:1997;1000-1016.
11. Stack W.A., et al. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment. Pharmacol. Ther. 16:2002;497-506.
12. Barnett K., et al. Role of cyclooxygenase-2 in modulating gastric acid secretion in the normal and inflamed rat stomach. Am. J. Physiol. 279:2000;G1292-G1297.
13. Souza, M.H. et al. Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis. Am. J. Physiol. (in press).
14. Fiorucci, S. et al. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. FASEB J. (in press).
15. Fiorucci, S. et al. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2 derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin. Br. J. Pharmacol. (in press).
16. 4 receptor. Nat. Med. 8:2002;1296-1302.
17. 4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J. Immunol. 168:2002;5260-5267.
18. 4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J. Exp. Med. 187:1998;1285-1294.
19. 4. Nat. Med. 8:2002;1018-1023.
20. 4 stable analog displays a unique topical anti-inflammatory profile. J. Immunol. 169:2002;7063-7070.